Shanghai KangaBio Co., Ltd.
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Latest From Shanghai KangaBio Co., Ltd.
$100m+ China Biotech VC/PE Financings Return In July
Pyrotech Therapeutics and Worg Pharmaceuticals are among the few Chinese biotechs to have bagged fresh large funding round from venture capital and private equity investors over the past month.
Deal Watch: Roche, PhoreMost Enter Into Multi-Target Collaboration
Plus deals with Synaffix/Emergence, Helsinn/Juniper and Sanyou/Shanghai KangaBio, while Takeda/Finch and Dong-A/Beactica ended prior collaborations.
Company Information
- Industry
- Biotechnology
- Pharmaceuticals
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Email Company
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice